ArticleCureus2025
Survival and Short-Term Morbidities Among Extremely Preterm Infants: A Prospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Survival without major morbidity in extremely preterm infants: a prospective multicenter study in Shenzhen, China.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOutcomes of extremely preterm (EPT) infants in low- and middle-income countries (LMIC) remain heterogeneous, with limited gestational age (GA)-defined data from India.
objectiveTo evaluate survival, short-term morbidities, and predictors of mortality among infants born ≤28 weeks' gestation in a North Indian tertiary neonatal intensive care unit (NICU).
methodsThis prospective observational cohort included all inborn infants ≤28 weeks admitted between November 2020 and October 2021, excluding those with major anomalies. Maternal, perinatal, and neonatal data were collected prospectively. The primary outcome was survival to discharge; secondary outcomes included major morbidities. Predictors of mortality were assessed using multivariable logistic regression.
resultsEighty-three infants were enrolled (median GA 27.0 weeks (IQR 26.3-27.9); median birth weight 892 g (IQR 731-1021)). Overall survival to discharge was 61.4%, with survival increasing with gestational age. Sepsis (37.5%) and extreme prematurity (40%) were leading causes of death. Major morbidities included sepsis (61.4%), bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age (PMA) (41.5% any grade, 15.1% moderate-severe), necrotizing enterocolitis (NEC) ≥ stage II (13.3%), severe intraventricular hemorrhage (IVH) (12.0%), and treatment-requiring retinopathy of prematurity (ROP) (7.8%). In adjusted analysis, higher birth weight (adjusted odds ratio (AOR) 0.59 per 100 g increase; 95% CI 0.37-0.94) and higher five-minute Apgar score (aOR 0.25 per point; 95% CI 0.13-0.48) independently predicted survival. The final model demonstrated excellent discrimination (area under the curve (AUC) 0.89, 95% CI 0.83-0.96).
conclusionsSurvival of EPT infants in this Indian cohort was higher than pooled LMIC estimates but remained lower than high-income benchmarks. Birth weight and five-minute Apgar score were the strongest predictors of outcome. Strengthening perinatal care, infection prevention, and standardized neonatal practices may further improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.